← Back to Search

GeoHAI App for Healthcare-Associated Infections

Led By Courtney Hebert, MD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial uses GIS and spatial analysis to create a new computer app to help hospital epidemiologists map & identify clusters of hospital-acquired infections to better prevent them.

Who is the study for?
This trial is for infection preventionists and physicians who are involved in infection control at the participating health system. It's not open to those who aren't in this role or don't work within the specified healthcare setting.Check my eligibility
What is being tested?
The study is testing GeoHAI, a new computer application that uses mapping and geographic data to help hospital epidemiologists identify clusters of Hospital Acquired Infections (HAIs) and assess transmission risks.See study design
What are the potential side effects?
Since GeoHAI is a computer application rather than a drug or medical procedure, it does not have physical side effects. However, its implementation may affect workflow and decision-making processes.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Healthcare-Associated Infection (HAI) Rate
Secondary outcome measures
Change from baseline skill confidence at one year
Change in Healthcare-Associated Infection (HAI) Investigation Process
Feasibility score
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: GeoHAI UseExperimental Treatment1 Intervention
Participants will use the GeoHAI tool

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
826 Previous Clinical Trials
502,660 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,822,323 Total Patients Enrolled
Courtney Hebert, MDPrincipal InvestigatorOhio State University

Media Library

GeoHAI Use Clinical Trial Eligibility Overview. Trial Name: NCT05612672 — N/A
Clostridioides difficile Infection Research Study Groups: GeoHAI Use
Clostridioides difficile Infection Clinical Trial 2023: GeoHAI Use Highlights & Side Effects. Trial Name: NCT05612672 — N/A
GeoHAI Use 2023 Treatment Timeline for Medical Study. Trial Name: NCT05612672 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant quota for this particular experiment?

"Affirmative. According to information found on clinicaltrials.gov, this examination is currently searching for participants, having been initially posted February 13th 2023 and last updated March 13th 2023. The trial requires 25 patients at a single site."

Answered by AI

Is this experiment actively recruiting participants?

"Correct. According to clinicaltrials.gov, this medical research is enrolling patients since its initial posting on February 13th 2023 and the most recent update was on March 13th 2023. The study requires 25 participants recruited from 1 trial centre."

Answered by AI
~7 spots leftby Sep 2024